Pellegrino E D
Center for Clinical Bioethics, Georgetown University Medical Center, Washington, DC, USA.
J Clin Ethics. 1995 Winter;6(4):312-7.
In their commentary on the recent report on the ethics of managed care by the American Medical Association's (AMA) Council on Ethical and Judicial Affairs, Miles and Koepp offer two salient criticisms: For one thing, they fault the Council for not disclosing how intellectual, legal, and financial conflicts of interest may have influenced the Council's ethical opinions. Specifically, they point to the AMA's customary interest in preserving the fee-for-service system and in avoiding potential litigation that might arise from strictures imposed on rulings of the Council on Ethical and Judicial Affairs by the Federal Trade Commission (FTC). For another, Miles and Koepp decry the Council's focus on the ethical obligations of individual physicians to their own patients to the neglect of their obligations to the healthcare plan, the other patients in the plan, and to society at large. Specifically, they lament the lack of a well-developed ethic of distributive justice and collective governance suitable to the economic exigencies of allocating resources. In this commentary, I wish to examine more closely two issues raised by Miles and Koepp's critique. The first issue is the assumption that the existence of interests--and, therefore, the possibility of conflicts of interest--is relevant in assigning validity to the conclusions of an ethical deliberation and that full disclosure is helpful in determining that validity. The second issue is the proper ethical relationship that should obtain between the obligations of physicians, to their own patients with whom they have a covenant of trust, and the obligations they incur to a health plan or to society when they sign a contract as a participating physician. This is part of the more general question of the proper relationship between commutative and distributive justice when they are in conflict. A third issue, which neither Miles and Koepp nor I address is the ethical propriety or moral legitimacy of restraints imposed by the FTC on the ethical guidelines of a profession. Should the FTC's legal hegemony over competition overrule the integrity of professional ethics? Should it make any difference in the Council's ethical opinions? This is a subject for more extended treatment than I can give it here. Suffice it to say that the rulings of the FTC are legal, not ethical, rulings. As such, their validity must be subjected to the same critical examination as other ethical statements. The mere existence of an FTC ruling, its practical consequences notwithstanding, is no warrant for abandoning an ethical principle. This is particularly the case since the FTC has made the protection of competition its icon and endowed it with a quasi-ethical authority. My commentary is not an item-by-item apologia for the Council's report. I do agree with, and wish to defend, its emphasis on the primacy of the physician's obligation to his or her patient even in a managed-care system. But I also agree with Miles and Koepp that a fuller development of an ethic of distributive justice is in order. I suspect they would frame their ethic differently than would I. I do not agree with them, however, that disclosure of interests would help to judge the ethical validity of the Council's opinions, except in a limited way. Lest I be suspected of a conflict of interest, I must state at the outset that I had no part in drafting the Council's report and that I have no personal or intellectual commitment to fee-for-service per se. The report did cite a work of mine, however, and I do have an interest in clarifying its relevance to the issues in question.
在对美国医学协会(AMA)伦理与司法事务委员会最近发布的关于管理式医疗伦理的报告的评论中,迈尔斯和凯普提出了两点突出的批评:一方面,他们指责该委员会没有披露智力、法律和财务利益冲突可能如何影响委员会的伦理观点。具体而言,他们指出美国医学协会惯常关注维护按服务收费体系,并避免因联邦贸易委员会(FTC)对伦理与司法事务委员会的裁决施加限制而可能引发的潜在诉讼。另一方面,迈尔斯和凯普谴责该委员会将重点放在个体医生对其自身患者的伦理义务上,而忽视了他们对医疗保健计划、该计划中的其他患者以及整个社会的义务。具体来说,他们 lament 缺乏一种适合资源分配经济紧迫性的完善的分配正义和集体治理伦理。在这篇评论中,我想更仔细地研究迈尔斯和凯普的批评所引发的两个问题。第一个问题是这样一种假设,即利益的存在——因此利益冲突的可能性——与赋予伦理审议结论有效性相关,并且充分披露有助于确定这种有效性。第二个问题是,当医生作为参与医生签署合同时,他们对与之有信任契约的自身患者的义务与他们对健康计划或社会所承担的义务之间应存在的适当伦理关系。这是交换正义和分配正义在冲突时两者之间适当关系这一更普遍问题的一部分。第三个问题,迈尔斯、凯普和我都没有涉及,即联邦贸易委员会对一个行业的伦理准则施加限制的伦理适当性或道德合法性。联邦贸易委员会对竞争的法律霸权是否应凌驾于职业道德的完整性之上?这对委员会的伦理观点应该有影响吗?这是一个需要比我在此所能给予的更广泛探讨的主题。可以说,联邦贸易委员会的裁决是法律裁决,而非伦理裁决。因此,其有效性必须接受与其他伦理陈述相同的批判性审查。仅仅存在联邦贸易委员会的一项裁决,无论其实际后果如何,都不能成为放弃一项伦理原则的理由。尤其如此,因为联邦贸易委员会已将保护竞争作为其标志,并赋予其一种准伦理权威。我的评论并非对委员会报告逐条进行辩护。我确实同意并希望捍卫其强调即使在管理式医疗体系中医生对其患者的义务的首要地位。但我也同意迈尔斯和凯普的观点,即发展一种更完善的分配正义伦理是必要的。我怀疑他们构建其伦理的方式会与我不同。然而,我不同意他们的观点,即披露利益有助于判断委员会观点的伦理有效性,除了在有限的程度上。以免有人怀疑我存在利益冲突,我必须一开始就声明我没有参与起草委员会的报告,并且我本身对按服务收费没有个人或智力上的倾向。不过,该报告确实引用了我的一部作品,我确实有兴趣阐明其与相关问题的关联性。 (注:lament 这个词在原文中拼写有误,正确拼写应为 lament,表示“惋惜、哀叹”等意思,这里按正确意思翻译了。)